Dka - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency leads to increased lipolysis and free fatty acid release, which the liver converts into ketone bodies, causing metabolic acidosis.

• Secondary mechanism: Hyperglycemia results from reduced cellular glucose uptake and increased gluconeogenesis, leading to osmotic diuresis and severe dehydration.

• Key complication: Acidosis and dehydration can precipitate electrolyte imbalances, particularly hyperkalemia, which may cause cardiac arrhythmias and other severe systemic effects.

Patient Profile

Demographics:

45-year-old female, software engineer

History:

• Key past medical history: Type 1 Diabetes Mellitus diagnosed 20 years ago, hypertension, chronic kidney disease stage 3

• Current medications: Insulin glargine, lisinopril, metoprolol, aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and confusion

• Key symptoms: Polyuria, polydipsia, nausea, vomiting, fatigue, shortness of breath

• Vital signs: Temperature 101.2°F, heart rate 130 bpm, respiratory rate 28 breaths/min, blood pressure 90/60 mmHg, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Upon initial assessment, the patient is found to be in significant distress, with lab results further complicating her DKA presentation. Blood glucose levels are alarmingly high at 680 mg/dL. Arterial blood gas analysis reveals a pH of 7.1, indicating severe metabolic acidosis, with a bicarbonate level of 10 mEq/L. Serum ketones are markedly elevated. Electrolyte analysis shows a potassium level of 6.5 mEq/L, pointing to significant hyperkalemia, while sodium is low at 130 mEq/L, indicating dilutional hyponatremia due to osmotic diuresis. The blood urea nitrogen (BUN) and creatinine levels are elevated, at 50 mg/dL and 3.2 mg/dL respectively, reflecting acute kidney injury superimposed on her chronic kidney disease. The elevated anion gap further corroborates the metabolic acidosis diagnosis.

Additionally, a chest X-ray is performed due to the patient's low oxygen saturation, revealing mild pulmonary congestion, suggesting possible fluid overload secondary to acute renal impairment. An ECG is conducted due to the risk of cardiac complications from hyperkalemia and reveals peaked T waves, consistent with the elevated potassium levels, increasing the risk for arrhythmias.

These diagnostic results emphasize the complexity of the patient's condition, necessitating prompt and strategic intervention to address not only the DKA but also the associated complications, including the electrolyte imbalances, renal impairment, and potential cardiac risks. This scenario requires advanced clinical reasoning to prioritize interventions that will stabilize the patient's hemodynamic status, correct metabolic derangements, and prevent further deterioration.

Section 2

Change in Patient Status:

Despite the initial interventions targeted at correcting the severe hyperglycemia and metabolic acidosis, the patient's condition escalates, presenting additional challenges. Approximately two hours after initiating treatment, which included intravenous insulin therapy and cautious fluid resuscitation with isotonic saline, the patient begins to exhibit signs of increasing respiratory distress. Her respiratory rate climbs to 32 breaths per minute, and her oxygen saturation drops further to 88% on a non-rebreather mask. Auscultation reveals bilateral crackles in the lung bases, suggesting worsening pulmonary congestion.

Concurrently, there is a notable change in her mental status. The patient, previously alert though distressed, now appears confused and lethargic, raising concerns about cerebral edema or the possibility of a concurrent central nervous system infection. Her blood pressure has decreased to 90/58 mmHg, and her heart rate has increased to 130 beats per minute, indicating possible compensatory mechanisms in response to hypovolemia or worsening acidosis despite fluid therapy.

Repeat laboratory work shows a slight improvement in blood glucose, now at 580 mg/dL, but her potassium level remains dangerously high at 6.2 mEq/L despite initial attempts at correction with insulin and bicarbonate therapy. Her arterial pH has improved marginally to 7.15, but the bicarbonate level remains low at 12 mEq/L, indicating persistent acidosis. These developments necessitate a rapid reassessment of the treatment strategy, with a focus on optimizing fluid management, continuing electrolyte monitoring, and possibly escalating to renal replacement therapy due to the patient's deteriorating kidney function and fluid balance. The clinical team must also consider advanced imaging and further neurological evaluation to elucidate the cause of her altered mental status, balancing aggressive intervention with careful monitoring for further complications.

Section 3

As the clinical team reevaluates the patient's condition, they decide to perform a computed tomography (CT) scan of the head to investigate the possibility of cerebral edema or other intracranial pathology contributing to her altered mental status. The imaging reveals mild cerebral edema, which warrants immediate intervention to prevent further neurological compromise. Mannitol is administered to reduce intracranial pressure, and the patient is closely monitored for any signs of improvement in mental clarity. Meanwhile, a lumbar puncture is considered to rule out a central nervous system infection, but the team must weigh the risks given her current hemodynamic instability.

Simultaneously, the patient's worsening respiratory status prompts a reassessment of her fluid management strategy. A chest X-ray confirms pulmonary edema, likely exacerbated by her compromised cardiac function and fluid overload. The team initiates diuretic therapy with intravenous furosemide to alleviate the pulmonary congestion while carefully balancing her fluid status to prevent further hypovolemia. Continuous cardiac monitoring reveals occasional premature ventricular contractions, likely due to the persistent hyperkalemia, necessitating urgent correction with calcium gluconate and additional insulin therapy to stabilize her cardiac rhythm.

In light of these developments, the nephrology team is consulted to evaluate the need for emergent renal replacement therapy. Given the patient's refractory hyperkalemia, worsening metabolic acidosis, and fluid overload, the decision is made to initiate continuous renal replacement therapy (CRRT). This approach allows for gradual correction of her electrolyte imbalances and acid-base status while providing better hemodynamic stability. The healthcare team remains vigilant, monitoring serum electrolytes, renal function, and neurological status closely, ready to adjust the therapeutic approach as the patient's condition evolves.

Section 4

As the healthcare team closely monitors the patient's response to the initiated interventions, a significant change in her status becomes apparent. Over the next several hours, the patient's neurological status shows subtle improvement with a slight increase in responsiveness, indicating a positive response to the administration of mannitol. However, her respiratory distress persists, and despite the diuretic therapy, her oxygen saturation remains precariously low, fluctuating between 85-88% on high-flow oxygen. Arterial blood gas analysis reveals persistent metabolic acidosis with a pH of 7.25, HCO3- at 12 mEq/L, and PaCO2 of 30 mmHg, underscoring the need for continued aggressive management of her acid-base balance.

Concurrently, the initiation of continuous renal replacement therapy (CRRT) begins to show promising results in stabilizing her electrolyte disturbances. Serial laboratory tests indicate a gradual decline in potassium levels, now measuring at 5.8 mEq/L, alongside a mild improvement in her bicarbonate levels. Despite these positive trends, the patient's fluid status remains a challenge. Her blood pressure exhibits labile tendencies, oscillating between hypotensive episodes at 85/50 mmHg and periods of hypertension peaking at 160/90 mmHg, necessitating cautious titration of vasopressors and fluid management. The risk of further cerebral and pulmonary complications demands meticulous reevaluation of her hemodynamic status and continuous adaptation of therapeutic strategies.

As the team presses forward, vigilance is key, particularly in light of new concerns regarding potential sepsis. The patient's white blood cell count has spiked to 18,000/mm³, and she exhibits a low-grade fever of 38.5°C, prompting the initiation of broad-spectrum antibiotics while blood cultures are obtained. This evolving scenario compels the team to reconsider the differential diagnosis, integrating these findings to anticipate further complications and adjust the treatment trajectory accordingly. Each clinical decision is critical, requiring advanced critical thinking to navigate the complexities of her deteriorating condition while safeguarding against potential cascading effects.

Section 5

As the healthcare team continues to grapple with the multifaceted challenges presented by the patient's condition, a significant change in her status becomes evident. Over the course of the next few hours, her respiratory pattern becomes more erratic, with episodes of tachypnea interspersed with periods of apnea. The high-flow oxygen therapy, while maintaining marginal oxygen saturation, is increasingly inadequate in addressing the underlying respiratory distress. A repeat arterial blood gas analysis reveals a slight worsening of metabolic acidosis, with a pH now at 7.22, HCO3- at 10 mEq/L, and PaCO2 remaining at 28 mmHg, indicating a growing respiratory component to her acid-base imbalance. This change prompts the team to consider the urgent need for mechanical ventilation to stabilize her breathing and optimize oxygen delivery.

Concurrently, the patient's cardiovascular status shows signs of further instability. Despite cautious titration of vasopressors, the labile blood pressure episodes have intensified, with systolic pressures plummeting to 75 mmHg during hypotensive phases. Central venous pressure measurements indicate potential hypovolemia, yet the risk of pulmonary edema from aggressive fluid resuscitation remains a critical consideration. The team's decision-making is further complicated by new electrocardiogram findings of peaked T waves, suggesting hyperkalemia despite ongoing CRRT, necessitating prompt intervention with calcium gluconate and insulin therapy.

Further complicating the clinical picture, the suspicion of sepsis is heightened by the emergence of new diagnostic results. Blood cultures return positive for Gram-negative bacilli, necessitating a shift in antibiotic therapy to target the identified pathogen more effectively. The patient's low-grade fever persists, now accompanied by signs of peripheral vasodilation and cool, clammy skin, suggestive of early septic shock. This development calls for an immediate reassessment of the therapeutic approach, with a focus on optimizing hemodynamic support and addressing the infectious source. Each decision is layered with complexity, requiring the team to continuously balance the competing priorities of respiratory support, hemodynamic stabilization, and infection control to navigate this precarious clinical landscape.